Fetal Growth Trajectories Among Small for Gestational Age Babies and Child Neurodevelopment

Kelly K Ferguson1, Sara Sammallahti2,3, Emma Rosen1

  • 1From the Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina.

Insights

Babies born small for gestational age (SGA) who were consistently small from mid-pregnancy showed worse neurodevelopmental outcomes, including lower IQ and more ADHD symptoms. Fetal growth patterns can help identify at-risk SGA infants.

Area of Science:

  • Pediatric Neurology
  • Developmental Pediatrics
  • Prenatal Medicine

Background:

  • Being born small for gestational age (SGA) is linked to adverse neurodevelopmental outcomes.
  • However, SGA encompasses diverse fetal growth patterns, not all leading to poor outcomes.
  • Identifying specific fetal growth trajectories is crucial for predicting neurodevelopmental risks in SGA infants.

Purpose of the Study:

  • To investigate whether fetal growth trajectories can differentiate neurodevelopmental outcomes in children born small for gestational age (SGA).
  • To compare cognitive and behavioral outcomes at age 6 between SGA infants with different fetal growth patterns and non-SGA infants.

Main Methods:

  • Utilized group-based trajectory modeling on ultrasound data from mid-pregnancy and late pregnancy, plus birth weight, for SGA infants (n=656) in the Generation R cohort (N=5,487).
  • Compared nonverbal intelligence quotient (IQ) and ADHD symptoms at age 6 between SGA subgroups and non-SGA controls.

Main Results:

  • Identified three distinct fetal weight growth trajectories among SGA infants.
  • Infants consistently small from mid-pregnancy (n=64) exhibited significantly lower IQ (7 points lower) and slightly increased ADHD symptoms compared to non-SGA peers.
  • SGA infants whose growth slowed later in pregnancy showed neurodevelopmental outcomes similar to non-SGA infants.

Conclusions:

  • Fetal growth trajectories are important for understanding neurodevelopmental outcomes in SGA children.
  • Consistently small fetal growth from mid-pregnancy is associated with the poorest neurodevelopmental outcomes at age 6.
  • Fetal growth trajectory analysis can aid in identifying SGA infants at higher risk for adverse neurodevelopmental trajectories.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.3K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
21.2K
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
43.6K